Mitochondrial DNA Haplogroups and Susceptibility to Prostate Cancer in a Colombian Population

Overview

Journal ISRN Oncol

Specialty Oncology

Date 2014 Mar 12

PMID 24616820

Citations 4

Authors

D Cano

C F Gomez

N Ospina

J A Cajigas

H Groot

R E Andrade

M M Torres

Affiliations

Soon will be listed here.

Abstract

Prostate cancer (PC) is one of the most common cancers and the second leading cause of mortality from cancer in Colombian men. Mitochondrial DNA (mtDNA) haplogroups have been associated with the risk of PC. Several studies have demonstrated dramatic differences regarding the risk of PC among men from different ethnic backgrounds. The present study was aimed at assessing the relationship between mtDNA haplogroups and PC. The mitochondrial DNA hypervariable segment I (HSV-1) was sequenced in a population-based study covering 168 cases (CA) and 140 unrelated healthy individuals as a control group (CG). A total of 92 different mtDNA sequences were found in CA and 59 were found in the CG. According to the geographical origin attributed to each mtDNA haplogroup, 82% of the mtDNA sequences found in both groups were Native Americans (A, B, C, and D). The most frequent was A (41.1%CA-42.1%CG), followed by B (22.0%CA-21.4%CG), C (12.0%CA-11.4%CG), and D (6%CA-10.0%CG). A lower percentage of European haplogroups (U, H, K, J, M, T, and HV) were also found (13.1%CA-12.9%CG), likewise African haplogroups (L0, L1, L2, and L3) (6.5%CA-2.1%CG). There were no statistically significant differences between the distribution of mtDNA haplogroups in CA and the CG in this study.

Citing Articles

Mitochondrial DNA variation and cancer.

Kopinski P, Singh L, Zhang S, Lott M, Wallace D Nat Rev Cancer. 2021; 21(7):431-445.

PMID: 34045735 DOI: 10.1038/s41568-021-00358-w.

Mitochondrial biology and prostate cancer ethnic disparity.

Xiao J, Cohen P, Stern M, Odedina F, Carpten J, Reams R Carcinogenesis. 2018; 39(11):1311-1319.

PMID: 30304372 PMC: 6292412. DOI: 10.1093/carcin/bgy133.

Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.

Kalsbeek A, Chan E, Corcoran N, Hovens C, Hayes V Oncotarget. 2017; 8(41):71342-71357.

PMID: 29050365 PMC: 5642640. DOI: 10.18632/oncotarget.19926.

Association of Genes, Pathways, and Haplogroups of the Mitochondrial Genome with the Risk of Colorectal Cancer: The Multiethnic Cohort.

Li Y, Beckman K, Caberto C, Kazma R, Lum-Jones A, Haiman C PLoS One. 2015; 10(9):e0136796.

PMID: 26340450 PMC: 4560485. DOI: 10.1371/journal.pone.0136796.

References

Rubinstein S, Dulik M, Gokcumen O, Zhadanov S, Osipova L, Cocca M . Russian Old Believers: genetic consequences of their persecution and exile, as shown by mitochondrial DNA evidence. Hum Biol. 2009; 80(3):203-37. DOI: 10.3378/1534-6617-80.3.203. View

Kulawiec M, Arnouk H, Desouki M, Kazim L, Still I, Singh K . Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer. Cancer Biol Ther. 2006; 5(8):967-75. DOI: 10.4161/cbt.5.8.2880. View

Saric T, Brkanac Z, Troyer D, Padalecki S, Sarosdy M, Williams K . Genetic pattern of prostate cancer progression. Int J Cancer. 1999; 81(2):219-24. DOI: 10.1002/(sici)1097-0215(19990412)81:2<219::aid-ijc9>3.0.co;2-3. View

Salas A, Carracedo A, Macaulay V, Richards M, Bandelt H . A practical guide to mitochondrial DNA error prevention in clinical, forensic, and population genetics. Biochem Biophys Res Commun. 2005; 335(3):891-9. DOI: 10.1016/j.bbrc.2005.07.161. View

Darvishi K, Sharma S, Bhat A, Rai E, Bamezai R . Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 2006; 249(2):249-55. DOI: 10.1016/j.canlet.2006.09.005. View

Achilli A, Perego U, Bravi C, Coble M, Kong Q, Woodward S . The phylogeny of the four pan-American MtDNA haplogroups: implications for evolutionary and disease studies. PLoS One. 2008; 3(3):e1764. PMC: 2258150. DOI: 10.1371/journal.pone.0001764. View

van Oven M, Kayser M . Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2008; 30(2):E386-94. DOI: 10.1002/humu.20921. View

Xu L, Hu Y, Chen B, Tang W, Han X, Yu H . Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int J Gynecol Cancer. 2006; 16(4):1661-7. DOI: 10.1111/j.1525-1438.2006.00641.x. View

Dakubo G, Parr R, Costello L, Franklin R, Thayer R . Altered metabolism and mitochondrial genome in prostate cancer. J Clin Pathol. 2006; 59(1):10-6. PMC: 1860255. DOI: 10.1136/jcp.2005.027664. View

10.

Carvajal-Carmona L, Soto I, Pineda N, Ortiz-Barrientos D, Duque C, Ospina-Duque J . Strong Amerind/white sex bias and a possible Sephardic contribution among the founders of a population in northwest Colombia. Am J Hum Genet. 2000; 67(5):1287-95. PMC: 1288568. DOI: 10.1016/S0002-9297(07)62956-5. View

11.

Parr R, Maki J, Reguly B, Dakubo G, Aguirre A, Wittock R . The pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretation. BMC Genomics. 2006; 7:185. PMC: 1538596. DOI: 10.1186/1471-2164-7-185. View

12.

Canter J, Kallianpur A, Fowke J . Re: North American white mitochondrial haplogroups in prostate and renal cancer. J Urol. 2006; 176(5):2308-9. DOI: 10.1016/j.juro.2006.07.067. View

13.

Fliss M, Usadel H, Caballero O, Wu L, Buta M, Eleff S . Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000; 287(5460):2017-9. DOI: 10.1126/science.287.5460.2017. View

14.

Amundadottir L, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson B . A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006; 38(6):652-8. DOI: 10.1038/ng1808. View

15.

Alves-Silva J, da Silva Santos M, Guimaraes P, Ferreira A, Bandelt H, Pena S . The ancestry of Brazilian mtDNA lineages. Am J Hum Genet. 2000; 67(2):444-61. PMC: 1287189. DOI: 10.1086/303004. View

16.

Croteau D, Bohr V . Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997; 272(41):25409-12. DOI: 10.1074/jbc.272.41.25409. View

17.

Salas A, Richards M, Lareu M, Scozzari R, Coppa A, Torroni A . The African diaspora: mitochondrial DNA and the Atlantic slave trade. Am J Hum Genet. 2004; 74(3):454-65. PMC: 1182259. DOI: 10.1086/382194. View

18.

Mueller E, Eder W, Mayr J, Paulweber B, Sperl W, Horninger W . Mitochondrial haplogroups and control region polymorphisms are not associated with prostate cancer in Middle European Caucasians. PLoS One. 2009; 4(7):e6370. PMC: 2712094. DOI: 10.1371/journal.pone.0006370. View

19.

Bandelt H, Quintana-Murci L, Salas A, Macaulay V . The fingerprint of phantom mutations in mitochondrial DNA data. Am J Hum Genet. 2002; 71(5):1150-60. PMC: 385090. DOI: 10.1086/344397. View

20.

Singh K, Kulawiec M . Mitochondrial DNA polymorphism and risk of cancer. Methods Mol Biol. 2008; 471:291-303. PMC: 2825891. DOI: 10.1007/978-1-59745-416-2_15. View